Literature DB >> 6742782

Autosomal dominant inheritance of hereditary canine spinal muscular atrophy.

G H Sack, L C Cork, J M Morris, J W Griffin, D L Price.   

Abstract

Hereditary canine spinal muscular atrophy ( HCSMA ) is a motor neuron disease in Brittany spaniels. Three phenotypes are recognized (accelerated, intermediate, and chronic) and are distinguished on the basis of rate of progression and age at onset. Breeding studies within a kindred of more than 125 dogs (Brittany spaniel and beagle-Brittany outcrosses ) have established an autosomal dominant inheritance for HCSMA . Pups homozygous for the trait have accelerated disease whereas heterozygous dogs have intermediate or chronic disease. The reason for the two phenotypes in heterozygotes is under study. HCSMA provides a unique opportunity to study the genetic and pathophysiological mechanisms of a motor neuron disease, and findings may have broad relevance to investigations of autosomal dominant degenerative disorders of the central nervous system.

Entities:  

Mesh:

Year:  1984        PMID: 6742782     DOI: 10.1002/ana.410150411

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

Review 1.  Abiotrophy in domestic animals: a review.

Authors:  A de Lahunta
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

2.  Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease.

Authors:  M J Pinter; R F Waldeck; T C Cope; L C Cork
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

3.  Hereditary canine spinal muscular atrophy: canine motor neuron disease.

Authors:  L C Cork; D L Price; J W Griffin; G H Sack
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

4.  Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.

Authors:  Xinghua Yin; Grahame J Kidd; Erik P Pioro; Jennifer McDonough; Ranjan Dutta; M Laura Feltri; Lawrence Wrabetz; Albee Messing; Ryan M Wyatt; Rita J Balice-Gordon; Bruce D Trapp
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.